Jointly sponsored by the Perelman School of Medicine at the University of Pennsylvania

Content Links:
Series Overview:
The Perelman School of Medicine at the University of Pennsylvania and ViralEd are proud to announce the extension of this ground-breaking CME activity. Mirroring academic grand rounds programs, these CME-certified sessions combine traditional academic grand rounds with the innovation and convenience of telemedicine. The "HIV Grand Rounds from the Perelman School of Medicine at the University of Pennsylvania" is delivered live via the Internet weekly and archived for on-demand viewing twenty-four hours after each live broadcast.
Presentations cover the most important and current topics in HIV/AIDS and are delivered by the top experts in the field. They are designed to be immediately relevant to practicing HIV clinicians and many are case-based. The final 10 minutes of each one-hour activity consists of a question and answer period. These weekly grand rounds are intended to provide clinicians with convenient and easily accessible knowledge and clinical skills they need to provide the best medical care for their HIV-positive patients.
Each session may be broadcast via your Internet connection in your conference room or auditorium for large groups to view, or individually to your personal computer at your convenience. Simply register at www.viraled.com/grandrounds for easy access.
Target Audience:
This educational activity is designed for HIV specialists, Infectious Disease specialists, Internal Medicine specialists, Family Practice physicians, Dermatologists, Osteo-specialists, Nephrologists, Hematology/oncologist, Psychiatrists, Public Health professionals, OB/GYN physicians and other clinicians interested and involved in the care of patients with HIV/AIDS.
Commercial Support Acknowledgement:
These activities are supported by educational grants from Gilead Sciences Medical Affairs and Janssen Pharmaceuticals, Inc.
Learning Objectives for the Series:
Upon completion of the educational activity, participants should be able to:
-
Improve knowledge and ability to use ARV therapy successfully;
-
Improve the knowledge of how drug adverse events, drug pharmacokinetics and patient adherence can affect ARV success and through the application of this knowledge avoid morbidity and mortality;
-
Improve knowledge of opportunistic infections and co-morbidities that may affect HIV-positive patients and increase their risk for morbidity and mortality;
-
Improve understanding of the importance of individualizing the care of each HIV-positive patient.
Course Directors:
 |
John G. Bartlett, MD
Chief, Division of Infectious Diseases
Stanhope Bayne Jones Professor of Medicine
Director, HIV Care Program
Johns Hopkins School of Medicine
Baltimore, Maryland
|
 |
Calvin J. Cohen, MD, MS
Research Director
CRI New England
Clinical Instructor
Harvard Medical School
Boston, Massachusetts
|
 |
Ian Frank, MD
Professor of Medicine,
Director, Clinical Therapeutics Program
Penn Center for AIDS Research
Perelman School of Medicine at the University of Pennsylvania
Philadelphia, Pennsylvania
|
|
|
Faculty:
Jay Kostman, MD
Clinical Associate Professor of Medicine
Division of Infectious Diseases
Chief, Infectious Diseases Division,
Penn Presbyterian Medical Center
University of Pennsylvania
Philadelphia, Pennsylvania
|
K. Rajender Reddy, MD
Professor of Medicine,
Professor of Medicine in Surgery,
Director of Hepatology,
Medical Director of Liver Transplantation
University of Pennsylvania School of Medicine
Philadelphia, Pennsylvania
|
Vincent Lo Re, III, MD
Clinical Associate Professor of Medicine,
Division of Infectious Diseases
Penn Presbyterian Medical Center
University of Pennsylvania
Philadelphia, Pennsylvania
|
Robert Siliciano, MD, PhD
Professor of Medicine,
Molecular Biology and Genetics,
Howard Hughes Medical Institute
Johns Hopkins University School of Medicine
Baltimore, Maryland
|
Priscilla Hsue, MD
Associate Professor of Medicine,
Division of Cardiology
University of California, San Francisco
School of Medicine
San Francisco, California
Back to Top |
Louis J. Picker, MD
Associate Director,
Vaccine and Gene Therapy Institute
Head, Pathobiology and Immunology Division
Oregon Health and Science University
Portland, Oregon
|
Timothy Wilkin, MD, MPH
Associate Professor of Medicine,
Division of Infectious Diseases
Weill Medical College of Cornell University
New York, New York
|
David Wohl, MD
Associate Professor of Medicine,
Division of Infectious Diseases, School of Medicine,
The University of North Carolina, Chapel Hill, North Carolina
Co-Director of HIV Services for the North Carolina
Department of Corrections
Chapel Hill, North Carolina
|
Steven G. Deeks, MD
Professor of Medicine,
University of California, San Francisco
San Francisco, California
|
Pablo Tebas, MD
Professor of Medicine
University of Pennsylvania
Philadelphia, Pennsylvania
|
Todd Barton, MD
Associate Professor of Medicine,
The Perelman School of Medicine at the University of Pennsylvania
Philadelphia, Pennsylvania
Back to Top |
Ian McGowan, MD
Professor of Medicine,
Division of Gastroenterology, Hepatology and Nutrition
University of Pittsburgh School of Medicine
Pittsburgh, Pennsylvania
|
Chloe L. Thio, MD
Professor of Medicine,
Division of Infectious Diseases
John Hopkins University
Baltimore, Maryland
|
Renslow Sherer, MD
Professor of Medicine,
Section of Infectious Diseases and Global Health,
University of Chicago
Chicago, Illinois
|
Charles Hicks, MD
Professor of Medicine
Department of Infectious Diseases
Duke University Medical Center
Durham, North Carolina
|
Beatrice Hahn, MD
Professor of Medicine and Microbiology
University of Pennsylvania
Philadelphia, Pennsylvania
|
Robert M. Grant, MD, MPH
Betty Jean and Hiro Ogawa Endowed Investigator
Gladstone Institute of Virology and Immunology
Associate Professor of Medicine
University of California, San Francisco
San Francisco, California
Back to Top |
George M. Shaw, MD, PhD
Professor of Medicine
Division of Hematology / Oncology
University of Pennsylvania
Philadelphia, Pennsylvania
|
Robert Gross, MD, MSCE
Associate Professor of Medicine
Infectious Diseases Division
Associate Professor of Epidemiology
Department of Biostatistics and Epidemiology
University of Pennsylvania Perelman School of Medicine
Philadelphia, Pennsylvania
|
Doreen Ramogola-Masire, MD
Country Director and Lead Physician Women's Health
Botswana UPenn Partnership
Gaborone, Botswana
|
James D. Neaton, PhD
Professor of Biostatistics
University of Minnesota School of Public Health
Minneapolis, Minnesota
|
Una O'Doherty, MD, PhD
Associate Professor of Pathology
and Laboratory Medicine
The Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania
|
Michel C. Nussenzweig, PhD
Sherman Fairchild Professor
Rockefeller University
Investigator, HHMI laboratory of Molecular Immunology
New York, New York
Back to Top |
Valerianna Amorosa, MD
Chief of Infectious Diseases, VAMC Assistant Professor
of Clinical Medicine
The Perelman SOM at the University of Pennsylvania
Philadelphia, Pennsylvania
|
Michael R. Betts, PhD
Assistant Professor
Department of Microbiology
Perelman School of Medicine
University of Pennsylvania
|
Chris Beyrer, MD, MPH
Professor
Director, Johns Hopkins Fogarty AIDS International
Training and Research Program
Director, Johns Hopkins Center for Public health
and Human Rights
Senior Scientific Liaison, HIV Vaccine Trials Network
Associate Director of Public Health, Johns Hopkins Center for
Public Health
Baltimore, Maryland
|
Daniel Kuritzkes, MD
Chief, Division of Infectious Diseases
Brigham and Women's Hospital
Professor of Medicine, Harvard Medical School
Boston, Massachusetts
|
Thomas Coyne, MD, PhD
Department of Pathology
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania
|
Jeffrey Hafkin, MD
Fellow, Infectious Diseases
Perelman School of Medicine at the University of Pennsylvania
Philadelphia, Pennsylvania
|
Amy Pruitt, MD
Associate Professor of Neurology
Hospital at the University of Pennsylvania
Philadelphia, Pennsylvania
|
Ronald L. Wolf, MD, PhD
Associate Professor of Radiology
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania
Back to Top |
Corey Casper, MD, MPH
Associate Member, Vaccine and Infectious Disease, Public Health Science and Clinical Research Divisions
Fred Hutchinson Cancer Research Center
Associate Professor of Medicine, Epidemiology and Global Health University of Washington
Medical Director of Infection Control, Seattle Cancer Care Alliance
Seattle, Washington
|
Marshall J. Glesby, MD, PhD
Associate Professor of Medicine and
Associate Professor of Public Health
Weill Cornell Medical College
Associate attending Physician
New York-Presbyterian Hospital
New York, New York
|
David M. Margolis, MD
Professor of Medicine, Microbiology and Immunology,
Epidemiology
Director, Program in Translational Clinical Research
IGHID
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina
|
Peter W. Hunt, MD
Assistant Professor in Residence
University of California, San Francisco
San Francisco, California
|
Domenico Mavilio, MD, PhD
Group Leader,
Clinical and Experimental Immunology
Instituto Clinico Humanitas
Rozzano, Milano Italy
|
Luis Montaner, DVM, MSc, DPhil
Wistar Institute Professor of Medicine
Director, HIV-1 Immunopathogenesis Laboratory
The Wistar Institute
Philadelphia, Pennsylvania
Back to Top |
Paul E. Sax, MD
Clinical Director, Division of Infectious Diseases
Brigham and Women's Hospital
Associate Professor of Medicine
Harvard Medical School
Boston, Massachusetts
|
Roy M. Gulick, MD
Chief of the Division of Infectious Diseases
Professor of Medicine
Weill Medical College
Cornell University
New York, New York
|
Lawrence Corey, MD
President and Director
Fred Hutchinson Cancer Research Center
Professor, Medicine and Laboratory Medicine
University of Washington
Seattle, Washington
|
Vincent Lo Re III, MD
Clinical Associate Professor of Medicine,
Division of Infectious Diseases
Penn Presbyterian Medical Center
Perelman School of Medicine at the University of Pennsylvania
Philadelphia, Pennsylvania
|
Jay R. Kostman, MD
Clinical Associate Professor of Medicine
Division of Infectious Diseases
Chief, Infectious Diseases Division,
Penn Presbyterian Medical Center
Philadelphia, Pennsylvania
|
Mark Sulkowski, MD
Associate Professor of Medicine and
Medical Director, Viral Hepatitis Center
John Hopkins University School of Medicine
Baltimore, Maryland
|
Myron S. Cohen, MD
J. Herbert Bate Professor
Medicine, Microbiology and Immunology and Epidemiology
The University of North Carolina at Chapel Hill
Chapel Hill, North Carolina
|
|
Helen C. Koenig, MD, MPH
Clinical Assistant Professor
Hospital at the University of Pennsylvania
Physician, LAX Center
Philadelphia, Pennsylvania
Back to Top |
Baligh R. Yehia, MD, MSHP
Department of Medicine
University of Pennsylvania
Perelman School of Medicine
Philadelphia, Pennsylvania
|
|
Daniel E. Everitt, MD
Senior Medical Officer
TB Alliance
New York, New York
|
Martin Markowitz, MD
Clinical Director and Staff Investigator
Aaron Diamond AIDS Research Center
Aaron Diamond Professor at the Rockefeller University
New York, New York
|
|
Ned C. Sacktor, MD
Professor of Neurology
Johns Hopkins University School of Medicine
Joint Appointment, Department of International Health
Johns Hopkins Bloomberg School of Public Health
Baltimore, Maryland
|
Jennifer Cohn, MD, MPH
Assistant Professor and Director of the Global Health Equities Residency
University of Pennsylvania
Policy Advisor for East Africa for Medecins Sans Frontieres Access Campaign
Philadelphia, Pennsylvania
|
|
Robin J. Shattock PhD
Chair in Mucosal Infection and Immunity, Division of Infectious Diseases
Department of Medicine
Imperial College London
London, England
|
John W. Ward, MD
Director, Division of Viral Hepatitis
National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention
Centers for Disease Control and Prevention
Atlanta, Georgia
|
|
Kenneth Hugh Mayer MD
Medical Research Director, Fenway Health
Attending Physician, Beth Israel Deaconess Medical Center
Visiting Professor, Harvard School of Public Health
Boston, Massachusetts
Back to Top |
Elmi Muller, MD
Transplant Surgeon
Groote Schuur Hospital
Cape Town, South Africa
|
|
Karam Mounzer MD
Medical Director, Jonathan Lax Treatment Center
Clinical Associate Professor of Medicine
Penn Presbyterian Medical Center
Philadelphia, Pennsylvania
|
Andrew J. Muir, MD MHS
Associate Professor of Medicine
Division of Gastroenterology
Director, Gastroenterology / Hepatology Research
Duke Clinical Research Institute
Duke University School of Medicine
Durham, North Carolina
|
|
Thomas J. Hope PhD
Professor
Department of Cell and Molecular Biology
Northwestern University Feinberg School of Medicine
Chicago, Illinois
|
Mohamed Atta MD MPH
Associate Professor of Medicine Renal Division
Johns Hopkins School of Medicine
Baltimore, Maryland
|
|
David Holtzman MD
Infectious Disease
University of Pennsylvania
Philadelphia, Pennsylvania
Back to Top |
Marion G. Peters MD
Professor of Medicine
John V. Carbone MD Endowed Chair of Medicine
Chief of Hepatology Research
University of California
San Francisco, California
|
|
Kenneth E. Sherman MD PhD
Gould Professor of Clinical Medicine
Director, Division of Digestive Diseases
University of Cincinnati
Cincinnati, Ohio
|
Benoit Dubé MD
Assistant Professor of Clinical Psychiatry
Associate Director for Medical Student Education in Psychiatry
Perelman School of Medicine at the University of Pennsylvania
Philadelphia, Pennsylvania
|
|
David Haas MD
Professor of Medicine
Professor of Pharmacology
Professor of Pathology, Microbiology and Imunology
Vanderbilt University School of Medicine
Nashville, Tennessee
|
Richard E. Chaisson MD
Professor of Medicine
Director, Center for Tuberculosis research
Director, Center for AIDS Research
Johns Hopkins University School of Medicine
Professor of Epidemiology and International Health
Johns Hopkins Bloomberg School of Public Health
Baltimore, Maryland
|
|
Marcus Altfeld MD PhD
Professor of Medicine, Harvard Medical School
The Ragon Institute of MGH, MIT and Hartford
Boston, Massachusetts
Back to Top |
Hashem B. El-Serag, MD, MPH
Dan L. Duncan Professor of Medicine
Chief, Gastroenterology and Hepatology Section
Baylor College of Medicine
Houston, Texas
|
|
Susan Cu-Uvin, MD
Professor, Obstetrics and Gynecology and Medicine
Professor, Health Services, Policy and Practice
Director, Global Health Initiative
Brown University
The Miriam Hospital
Providence, Rhode Island
|
Peter S. Gilbert PhD
Member, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center
Principal Investigator, Statistical Center for the HIV Vaccine Trials Network
Research Professor, Department of Biostatistics
University of Washington
Seattle, Washington
|
|
Calvin J. Cohen, MD, MS
Research Director
CRI New England
Clinical Instructor
Harvard Medical School
Boston, Massachusetts
|
Ian Frank, MD
Professor of Medicine,
Director, Clinical Therapeutics Program
Penn Center for AIDS Research
Perelman School of Medicine at the University of Pennsylvania
Philadelphia, Pennsylvania
|
|
Nezam H. Afdhal, MD
Professor of Medicine
Harvard Medical School
Chief of Hepatology, Director of Liver Center
Beth Israel Deaconess Medical Center
Boston, Massachusetts
|
|
|
Obtaining CME Credit for Archived Sessions: Important Information
This section pertains only to those who would like CME credit. If you do not want CME credit, please proceed to the next section below.
-
The Perelman School of Medicine at the University of Pennsylvania provides credit for all archived sessions in this educational activity.
-
If CME credit is desired for any of these sessions, proceed to http://penncmeonline.com/user/register to create your personal CME account, or if you already have an account, click the "Yes, I want CME credit" button below. You will be redirected to their website.
-
After your personal CME account is established this one time, you will receive an email with your initial login information. Follow the link in the email to change your password and complete the one-time profile set up. Additional instructions may be found at http://penncmeonline.com/user_guides.
-
A complete listing of all archived sessions, as listed below in the next section, can be found on the UPenn CME website. Follow the "Yes, I want CME Credit" button below to view the selections and earn CME credit.
-
After clicking this button a new window will open and you will be redirected to the University of Pennsylvania Office of CME website for this activity.
Archived Session Topics and Speakers:
Each program below will be available for CME credit for one year. After that the programs will remain available for on-demand viewing only. Cessation of CME availability for any program over one year old will be noted by the quote: "This program is no longer available for CME credit but will remain available for viewing on demand."
This program is no longer available for CME credit but will remain available for viewing on demand.
|
This program is no longer available for CME credit but will remain available for viewing on demand.
|
This program is no longer available for CME credit but will remain available for viewing on demand.
|
This program is no longer available for CME credit but will remain available for viewing on demand.
|
This program is no longer available for CME credit but will remain available for viewing on demand.
|
This program is no longer available for CME credit but will remain available for viewing on demand.
|
This program is no longer available for CME credit but will remain available for viewing on demand.
|
This program is no longer available for CME credit but will remain available for viewing on demand.
|
This program is no longer available for CME credit but will remain available for viewing on demand.
|
This program is no longer available for CME credit but will remain available for viewing on demand.
|
This program is no longer available for CME credit but will remain available for viewing on demand.
|
This program is no longer available for CME credit but will remain available for viewing on demand.
|
Back to Top
|
|
This program is no longer available for CME credit but will remain available for viewing on demand.
|
This program is no longer available for CME credit but will remain available for viewing on demand.
|
This program is no longer available for CME credit but will remain available for viewing on demand.
|
This program is no longer available for CME credit but will remain available for viewing on demand.
|
This program is no longer available for CME credit but will remain available for viewing on demand.
|
This program is no longer available for CME credit but will remain available for viewing on demand.
|
This program is no longer available for CME credit but will remain available for viewing on demand.
|
This program is no longer available for CME credit but will remain available for viewing on demand.
|
Back to Top
|
|
This program is no longer available for CME credit but will remain available for viewing on demand.
|
This program is no longer available for CME credit but will remain available for viewing on demand.
|
This program is no longer available for CME credit but will remain available for viewing on demand.
|
This program is no longer available for CME credit but will remain available for viewing on demand.
|
This program is no longer available for CME credit but will remain available for viewing on demand.
|
January 12th, 2012
Speaker: Reuben S. Harris PhD
Topic: The Feasibility of Modulating Cellular DNA Mutating Enzymes as Next-generation HIV/AIDS Therapeutics
This program is no longer available for CME credit but will remain available for viewing on demand.
|
January 19th, 2012
Speaker: Daniel R. Kuritzkes MD
Topic: Clinical Significance of HIV-1 Drug-resistant Minority Variants
This program is no longer available for CME credit but will remain available for viewing on demand.
|
January 26th, 2012
Speakers: Ian Frank MD; Thomas Coyne MD PhD; Jeffrey Hafkin MD; Amy Pruitt MD; Ronald L. Wolf MD PhD
Topic: Real Cases from the Hospital of the University of Pennsylvania
This program is no longer available for CME credit but will remain available for viewing on demand.
|
Back to Top
|
|
February 2nd, 2012
Speaker: Corey Casper MD MPH
Topic: The Spectrum and Pathogenesis of HIV-associated Malignancies in Resource-limited Settings
This program is no longer available for CME credit but will remain available for viewing on demand.
|
February 9th, 2012
Speaker: Marshall J. Glesby MD PhD
Topic: Update on the Cardiovascular Complications of HIV Infection
This program is no longer available for CME credit but will remain available for viewing on demand.
|
This program is no longer available for CME credit but will remain available for viewing on demand.
|
February 23rd, 2012
Speaker: Peter W. Hunt MD
Topic: Inflammation and HIV Infection: A Paradigm Shift in the Management of HIV Disease
This program is no longer available for CME credit but will remain available for viewing on demand.
|
March 1st, 2012
Speakers: Ian Frank MD, Todd Barton MD & Valerianna Amorosa MD
Topic: Real Cases from the Hospital of the University of Pennsylvania: "Preventable" Lung Disease in HIV Infected Patients
This program is no longer available for CME credit but will remain available for viewing on demand.
|
March 9th, 2012
Speaker: Myron S. Cohen MD
Topic: Prevention of HIV-1 Infection
This program is no longer available for CME credit but will remain available for viewing on demand.
|
March 15th, 2012
Speaker: Domenico Mavilio, MD, PhD
Topic: Natural Cytotoxicity Receptors: New Insights on Their Role in the Context of g/d T-cell Responses
|
|
March 22nd, 2012
Speaker: Ian Frank MD
Topic: Highlights from the 19th Conference on Retroviruses and Opportunistic Infections
|
March 29nd, 2012
Speaker: Luis Montaner DMV MSc DPhil
Topic: HIV Control Mediated by Interferon-alpha Immunotherapy
|
Back to Top
|
|
April 5th, 2012
Speaker: Paul E. Sax MD
Topic: Contemporary Issues in the Management of Treatment-Experienced Patients
|
April 12th, 2012
Speaker: Roy M. Gulick MD MPH
Topic: ART Controversies 2012
|
April 19th, 2012
Speaker: Lawrence Corey MD
Topic: Control of HSV Infection: The Action Is in the Mucosa
|
April 26th, 2012
Speaker: Vincent Lo Re MD & Jay Kostman MD
Topic: Case Studies from the Hospital at the University of Pennsylvania
|
May 3rd, 2012
Speaker: Mark Sulkowski MD
Topic: An Update from the Annual Meeting of the European Association for the Study of the Liver
|
May 9th, 2012
Speaker: Myron S. Cohen MD
Topic: Prevention of HIV-1 Infection
|
May 16th, 2012
Speaker: Brandon F. Keele PhD
Topic: Understanding HIV Transmission, Early Replication and Viral Dissemination Using Non-human Primate Models
|
May 24th, 2012
Speaker: Helen C. Koenig MD, MPH; Ian Frank, MD
Topic: Case Studies from the Hospital of the University of Pennsylvania
|
May 31st, 2012
Speaker: Baligh R. Yehia MD, MSHP
Topic: Improving Patient Retention in HIV Care
|
June 7th, 2012
Speaker: Daniel Everitt, MD
Topic: Developing New Therapies to Treat Tuberculosis
|
Back to Top
|
|
June 14th, 2012
Speaker: Marty Markowitz, MD
Topic: Antiretroviral Therapy: Are Three Drugs Enough?
|
June 21st, 2012
Speaker: Ned C. Sacktor MD
Topic: Neurocognitive Dysfunction in Aging People with HIV Infection; An Emerging Epidemic?
|
June 28th, 2012
Speaker: Calvin Cohen MD MSC, Ian Frank MD
Topic: Real Cases...Not Necessarily from the Hospital at the University of Pennsylvania
|
|
September 13th, 2012
Speaker: Robin J. Shattock PhD
Topic: Optimising Vaginal Humoral Immunity to HIV-1
|
September 20th, 2012
Speaker: Ian Frank, MD
Topic: An Update from the XIX International AIDS Conference and 52nd ICAAC
|
September 27th, 2012
Speaker: John W. Ward, MD
Topic: Epidemiologic Challenges to Control and Eventual Elimination of HCV Transmission and Disease
This is a re-broadcast of the Viral Hepatitis Grand Rounds from the Perelman School of Medicine at the University of Pennsylvania from September 26th, 2012
|
|
|
|
Back to Top
|
|
October 25th, 2012
Speaker: Andrew J. Muir MD MHS
Topic: Current Status of HCV Treatment: Challenges, Expectations and Strategies for the Future
This is a re-broadcast of the Viral Hepatitis Grand Rounds from the Perelman School of Medicine at the University of Pennsylvania from October 24th, 2012
|
November 1st, 2012
Speaker: Thomas J. Hope PhD
Topic: Defining the Mechanisims of Heteresexual HIV Transmission
|
November 8th, 2012
Speaker: Mohamed Atta MD MPH
Topic: Renal Disease in HIV Infection
|
November 15th, 2012
Speaker: Helen Koenig MD MPH; Amy Pruitt MD: David Holtzman MD
Topic: Real Cases from the University of Pennsylvania: CNS Disease in Patients with a Decent CD4+ Count
|
|
|
November 29th, 2012
Speaker: Marian G Peters MD & Kenneth E. Sherman MD PhD
Topic: Treatment of HCV / HIV Co-infection & HIV / HEV Co-Infection
This is a re-broadcast of the Viral Hepatitis Grand Rounds from the Perelman School of Medicine at the University of Pennsylvania aired on November 28th, 2012
|
December 6th, 2012
Speaker: Benoit Dubé MD FRCPC
Topic: Treating Mental Illness in HIV Infected Patients
|
December 13th, 2012
Speaker: David Haas MD
Topic: Pharmacogenomics of HIV infection
|
December 20th, 2012
Speaker: K. Rajender Reddy MD
Topic: An Update from the 63rd AASLD
|
Back to Top
|
|
January 10th, 2013
Speaker: Richard E. Chaisson MD
Topic: Preventing HIV-Related Tuberculosis: Two Steps Forward...
|
January 17th, 2013
Speaker: Marcus Altfeld MD PhD
Topic: Innate Immune Responses in HIV Infection
|
January 17th, 2013
Speaker: Hashem B. El-Serag, MD MPH
Topic: HCV Disease Burden - Now and the Future
This is a re-broadcast of the Viral Hepatitis Grand Rounds program webcast on 1/23/13
|
January 31st, 2013
Speaker: Susan Cu-Uvin MD
Topic: 30 Years of Advances in HIV/AIDS: What has Changed for Women?
|
February 7th, 2013
Speaker: Peter S. Gilbert, PhD
Topic: Analysis of Immune Correlates of Protection in RV144 HIV Vaccine Efficacy Trial
|
February 14th, 2013
Speaker: Calvin J. Cohen, MD MSc & Ian Frank, MD
Topic: Real Cases - Which ARV Regimens do We Start With...As of Feb 2013
|
February 21st, 2013
Speaker: Ian Frank, MD
Topic: Real Cases from the Hospital at the University of Pennsylvania
|
February 21st, 2013
Speaker: Nezm H. Afdhal, MD
Topic: new Concepts in Screening and Diagnosis of HCV
This is a re-broadcast of the Viral Hepatitis Grand Rounds program webcast on 2/27/13 |
Each program above will be available for CME credit for one year. After that the programs will remain available for on-demand viewing only. Cessation of CME availability for any program over one year old will be noted by the quote: "This program is no longer available for CME credit but will remain available for viewing on demand."
The 26 one-hour pilot program lectures that ran from September 29, 2010 - May 4, 2011 are available for viewing. Follow the button below to view these activities.
Hardware/Software Notice:
You will need Internet to participate in this activity.
Accreditation Statement:
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Perelman School of Medicine at the University of Pennsylvania and ViralEd, Inc.. The Perelman School of Medicine at the University of Pennsylvania is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation Statement:
The Perelman School of Medicine at the University of Pennsylvania designates each enduring material for a maximum of 1 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosures:
It is policy at the Perelman School of Medicine at the University of Pennsylvania and ViralEd, Inc. for individuals who are in a position to control the content of an educational activity to disclose to the learners all relevant financial relationships that they have with any commercial interest that provides products or services that may be relevant to the content of this continuing medical education activity. For this purpose we consider relationships of the person involved in the CME activity to include financial relationships of a spouse or partner.
The intent of this policy is not to prevent expert faculty with relevant relationship(s) with commercial interest(s) from involvement in CME, but rather to ensure that Penn CME-certified activities promote quality and safety, are effective in improving medical practice, are based on valid content, and are independent of control from commercial interests and free of commercial bias. Peer review of all content was conducted for all faculty presentations whose disclosure information provided to the Penn Office of CME was found to contain relationships that created a conflict of interest relative to the topic of their presentation. In addition, all faculty were instructed to provide balanced, scientifically rigorous and evidence-based presentations.
The staff in the Office of CME at the Perelman School of Medicine at the University of Pennsylvania (Rodman Campbell, Mila Kostic, Belinda Rose, and Mindy Pollock Troy), our educational partner ViralEd, Inc. (Richard Gordon, Brian Boyle, MD, JD and Ed Hettman), and the peer reviewer, Zalman Agus, MD, Associate Dean for Continuing Medical Education, have reported that they have no relevant financial relationships with any commercial interests related to the content of this educational activity.
The following faculty or planning committee members have disclosed that they have no relevant financial relationships with any commercial interests related to the content of this educational activity:
Back to Top
John Bartlett, MD
|
Susan Cu-Uvin, MD
|
Robert Siliciano, MD
|
Todd Barton, MD
|
Chloe L. Thio, MD
|
Beatrice H. Hahn MD
|
Peter S. Gilbert, PhD
|
|
Geroge M. Shaw, MD PhD
|
Doreen Ramogola-Masire, MD
|
James D. Neaton, PhD
|
|
Michel C. Nussenzweig, MD PhD
Back to Top
|
Valeriana Amorosa, MD
|
Michael Betts PhD
|
|
Chris Beyrer MD MPH
|
Reuben S. Harris PhD
|
|
|
Ian McGowan, MD
|
Una O'Doherty MD PhD
|
Thomas Coyne MD PhD
|
Jeffrey Hafkin MD
|
Amy Pruitt MD
|
Ronald L. Wolf MD PhD
|
Corey Casper MD MPH
|
Myrone S. Cohen MD
|
Domenico Mavilio MD PhD
Back to Top
|
Brandon F. Keele PhD
|
|
|
Helen C. Koenig MD
|
Baligh R. Yehia MD MSHP
|
Ned C. Sacktor MD
|
Jennifer Cohn, MD
|
Robin J. Shattock PhD
|
John W. Ward MD
|
Elmi Muller MD
|
Thomas J. Hope PhD
|
David Holtzman MD
|
Benoit Dubé MD
|
Hashem B. El-Serag, MD MPH
|
|
The following faculty or planning committee members have reported the listed relevant financial relationships with commercial interests related to the content of this educational activity:
Name
|
|
Commercial Supporter
|
Relationship
|
|
|
|
|
Calvin Cohen, MD
|
|
Gilead; Bristol-Myers Squibb; Merck & Co.; Tibotec; ViiV
|
Contracted Research
|
|
|
Gilead; Bristol-Myers Squibb; Merck & Co.; Tibotec; Abbott
|
Consulting Fees
|
|
|
Gilead; Bristol-Myers Squibb; Merck & Co.; Tibotec
|
Speakers Bureaus
|
|
|
|
|
|
Ian Frank, MD
|
|
GlaxoSmithKline
|
Contracted Research
|
|
|
Gilead
|
Consulting Fees
|
|
|
|
|
Vincent Lo Re, III, MD
|
|
AstraZeneca, Bristol-Myers Squibb
|
Contracted Research
|
|
|
|
|
K. Rajender Reddy, MD
|
|
Merck, Genentech-Roche, Vertex, Gilead, Janssen, BMS
|
Advisory Board
|
|
|
Merck, BMS, Gilead, Vertex, Janssen, Abbot
|
Clinical Research - Support to the Institution
|
|
|
|
|
Priscilla Hsue, MD
|
|
Bristol-Myers Squibb, Gilead
|
Speakers Bureau
|
|
|
|
|
Louis Picker, MD
|
|
CMV Vector Technology
|
Contracted Research
|
|
|
|
|
Back to Top |
|
|
|
Timothy Wilkin, MD
|
|
GlaxoSmithKline
|
Contracted Research
|
|
|
|
|
David Wohl, MD
|
|
Merck & Co.; GlaxoSmithKline
|
Contracted Research
|
|
|
Tibotec; Gilead; Bristol-Myers Squibb; Abbott
|
Consulting Fees
|
|
|
|
|
Steven Deeks, MD
|
|
Merck & Co.; Gilead Sciences
|
Contracted Research
|
|
|
Tobira; ViiV
|
Consulting Fees
|
|
|
|
|
Pablo Tebas, MD
|
|
GlaxoSmithKline
|
Adjudication Committee
|
|
|
Cytheris
|
DSMB Committee
|
|
|
GlaxoSmithKline; BMS; Gilead; Pfizer; Vertex; Inovio
|
Contracted Research
|
Back to Top |
|
|
|
|
|
|
|
Renslow Sherer, MD
|
|
BMS
|
Grant Support for Research
|
|
|
Abbott
|
Grant Support for Research
|
|
|
Gilead
|
Advisory Board with Honoraria
|
|
|
Abbott
|
Advisory Board with Honoraria
|
|
|
|
|
Charles Hicks MD |
|
Argos |
Grand Support -PI |
|
|
BMS; Gilead; Merck; Tibotec / Janssen; GSK/ViiV |
Grant Support / Honorarium - PI / Advisory Board
|
|
|
|
|
Robert M. Grant MD MPH
|
|
Gilead - Donation of study drug for NIH funded research
|
Investigator
|
|
|
|
|
Robert Gross, MD, MSCE
|
|
BMS
|
Research Investigator
|
|
|
|
|
Daniel R. Kuritzkes, MD |
|
Abbott, BSC, Boehringer-Ingelheim, Gilead, Merck, Roche & ViiV |
Consultant
|
|
|
Gilead & Merclk |
Principal Investigator |
Back to Top |
|
Roche |
Speaker |
|
|
|
|
Marshall J. Glesby, MD, PhD |
|
Pfizer; SIGA Technologies |
Consultant |
|
|
Pfizer |
Clinical Trial Researcher |
|
|
|
|
David M. Margolis, MD |
|
Merck, BMS, Gilead, GSK |
Research & Materials Funding |
|
|
Gilead |
Common Stocki |
|
|
Merck, BMS, GSK, Chimerix, Boehringer, ViiV |
Consulting Honaria |
|
|
Argos, Tibotec |
Clinical Trial Funding |
|
|
|
|
Peter W. Hunt, MD |
|
Merck |
Consultant |
|
|
Pfizer, Salix, Roche |
Investigator-Initiated Study |
|
|
Boehringer-Ingelheim, Gilead |
Speaker |
|
|
|
|
Luis J. Montaner, DVM, MSc, DPhil |
|
Pfizer |
Research Investigator |
Back to Top |
|
|
|
|
|
|
|
Paul E. Sax, MD |
|
Abbott, Aileron, BMS, Gilead, GSK, Merck, Tibotec |
Consultant |
|
|
BMS, Gilead, Merck, GSK, Tibotec |
Hospital Grant |
|
|
|
|
|
|
|
|
Roy M. Gulick, MD, MPH |
|
BMS, Gilead, Janssen |
Ad-hoc Consultant (honorarium) |
|
|
|
|
|
|
|
|
Lawrence Corey, MD |
|
Immune Design Corp |
Stock holder; Scientific Advisory Board |
|
|
|
|
|
|
|
|
Vincent Lo Re III, MD |
|
AstraZeneca, Bristol-Myers Squibb |
Contracted Research
|
Back to Top |
|
|
|
|
|
|
|
Jay Kostman, MD |
|
Vertex |
Consultant |
|
|
Merck |
Consultant |
|
|
|
|
|
|
|
|
Mark Sulkowski, MD |
|
Abbott, BMS, Gilead, Janssen, Merck,Roche, Vertex, Boehringer Ingelheim |
Research Gra nt to John Hopkins University (PI) |
|
|
Abbott, BMS, Gilead, Janssen, Merck,Roche, Vertex, Boehringer Ingelheim |
Scientific Advisory Panel |
|
|
|
|
|
|
|
|
Daniel E. Everitt, MD |
|
TB Alliance
|
Salary & Bonus as full time employee |
|
|
PRESENTERS NOTE: The TB Alliance is a non-profit organization funded by government & private foundation (Gates) grants. It receives no revenue from product sales but works in partnerships to develop new drug regimens for treating tuberculosis.
|
|
|
|
|
|
|
|
|
|
Martin Markowitz, MD |
|
Merck: Glead; Janssen; GSK; ViiV |
Consultatn = Honorarium |
|
|
Gilead; Janssen; BMS |
Speaker - Honorarium |
Back to Top |
|
|
|
|
|
|
|
Kenneth Hugh Mayer MD |
|
Gilead, Merck & BMS |
Research Grant for PI
|
|
|
|
|
|
|
|
|
Andrew J. Muir MD MHS |
|
Abbott, Achillion, BMS, Gilead, GSK, GlobeImmune, Medtronic, Merck, Pfizer, Roche, Salix, Scynexis, Vertex Pharmaceuticals
|
Grant / Research Funding
|
|
|
Achillion, BMS, Merck, Profectus BioSciences Inc., Scynexis, Vertex Pharmaceuticals
|
Consulting or Other Services (including CME) |
|
|
|
|
Karam Mounzer MD |
|
Gilead Sciences |
Research |
|
|
Gilead Sciences |
Speaker |
|
|
|
|
|
|
|
|
Mohamed Atta MD MPH |
|
GSK, BMS |
Advisory |
|
|
GSK |
Speaker |
|
|
Gilead |
Subcontract Grant PI |
Back to Top |
|
|
|
|
|
|
|
David W. Haas MD |
|
Gilead Sciences, Merck, Boehringer-Ingelheim |
PI on research grant to Vanderbilt University |
|
|
|
|
|
|
|
|
Richard E. Chaisson MD |
|
Merck |
Stock (wife is shareholder)
|
|
|
Vertex |
Consulting fees
|
|
|
|
|
Marcus Altfeld MD PhD
|
|
Gilead
|
Speaker Honorarium |
|
|
|
|
Calvin J. Cohen, MD MSc
|
Gilead; Bristol-Myers Squibb; Merck & Co.
|
Contracted Research
|
|
Gilead; Bristol-Myers Squibb; Merck & Co.; Tobira
|
Honararia
|
Ian Frank, MD
|
Gilead
|
Advisor; honorarium
|
|
GlaxoSmithKline
|
Grant for Contracted research
|
Ian Frank, MD |
Gilead
|
Advisor; honorarium
|
|
GlaxoSmithKline
|
Grant for Contracted research
|
Nezam H. Afdhal, MD |
Merck, GSK, Vertex, Gilead, Abbott, BMS |
Research Support |
|
Merck, Gilead, Echosens, GSK, Vertex, Novartis, Boehringer Ingelheim, Ligan, Springbank, Medgenics, Kadmon |
Consultant / Advisory Board Member |
|
Springbank, Medgenics |
Stock Options |
Disclosure of Unlabeled Use:
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. ViralEd, Inc., the Perelman School of Medicine at the University of Pennsylvania, Gilead Sciences and Janssen Therapeutics do not recommend the use of any agent outside of the labeled indications.
Product |
Investigational and/or Off-label Use |
Amy Pruitt, MD
|
|
Methohexate, rituxan, tenodex |
Treatment of primary CNS lymphoma |
|
|
Peter W. Hunt MD |
|
Dr. Hunt indicated that: |
His presentation will contain discussion of ongoing research studies of drugs targeting immune activation in treated HIV infection with the understanding that these developments cannot yet be recommended for clinical use as there is no evidence to support their use at this time. |
Back to Top |
|
|
|
Luis J. Montaner, DVM, MSc, DPhil |
|
Interferon-alpha 2a (Roche/Genentech) |
Ind for HIV mono-infected |
|
|
Roy M. Gulick, MD, MPH |
Investigational Antiretroviral Drugs (multiple) |
|
|
Jay Kostman, MD |
|
Telaprevir |
Co-infection |
Boceprevir |
Co-infection |
|
|
Mark Sulkowski, MD |
Multiple experimental HCV agents |
|
|
|
|
Daniel E. Everitt, MD |
Clofazimine - Investigational use to treate TB |
|
Moxifloxacin - Investigational use to treate TB |
|
|
|
|
Calvin Cohen, MD, MSC |
|
All approved HIV Antivirals |
All Current studies exploring off label uses |
Experimental HIV Antivirals |
Use of these for HIV treatment |
Back to Top |
|
|
|
Kenneth Hugh Mayer MD |
|
Maraviroc, Dapivirine. Rilpivirine |
Chemoprophylaxis |
|
|
|
|
Amy Pruitt MD |
|
Mefloquine & Codofovir |
Progressiive Multifocal Leukoencephalopathy |
Corticosteroids |
Immune Reconstitution Inflammatory syndrome / Progressiive Multifocal Leukoencephalopathy |
|
|
Helen Koenig MD MPH |
|
Mirtazapine; Mefloquine; Cytarabine; Cidofovir |
Progressiive Multifocal Leukoencephalopathy Treatment |
|
|
K. Rajendar Reddy MD |
I will mention several investigational drugs in clinical trials but will NOT discuss or promote off label use. The gist of the talk is to discuss recent advances in HCV therapy. |
|
|
Richard E. Chaisson MD |
|
Rifapentine |
Prevention of tuberculosis (currently labeled only for treatment of TB disease but recommended by the CDC for prevention |
|
|
|
|
Marcus Altfeld MD PhD |
|
IMO-3100 (TLR 7/9 Antagonist) |
Investigational drug developed by Idera Pharmaceuticals for psoriasis |
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of ViralEd, Inc., the Perelman School of Medicine at the University of Pennsylvania, Gilead Sciences and Janssen Therapeutics. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.
Disclaimer:
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
You may contact Richard Gordon by phone at 1-856-506-5790 or by email at rgordon@viraled.com for additional assistance.
For CME questions please contact the Perelman School of Medicine at the University of Pennsylvania Office of CME: upennCME@mail.med.upenn.edu.
We look forward to bringing the highest quality CME directly to you.
 Back to Top |